P16High-Expressing Immune Cells Control Disease Tolerance As A Defense And Health Span-Extending Strategy
Our bodies have remarkable ways of defending themselves against illness. Beyond simply fighting off germs, a newly identified defense mechanism, called “disease tolerance,” helps us limit the damage caused by infections and other severe conditions, even if the germs themselves aren’t immediately eliminated.
Recent research has shed light on a crucial player in this defense: a specific type of immune cell that expresses high levels of a protein called p16. These “p16-high immune cells” act as vital mediators of disease tolerance. They don’t necessarily kill pathogens, but instead work to protect our tissues and organs from harm during times of stress, such as severe infections or exposure to harmful radiation.
Scientists discovered that a key communication pathway within our cells, known as the MDA5-STING pathway, is responsible for triggering the production of these protective p16-high immune cells. By understanding and potentially modulating this pathway, we could enhance our natural defenses.
The implications of this discovery are significant. These p16-high immune cells have been shown to be essential for protecting against a range of life-threatening conditions, including severe bacterial infections and the damage caused by radiation. Interestingly, the FDA-approved mRNA COVID-19 vaccine (BNT162b2) was found to rapidly induce these beneficial immune cells in both mice and humans, suggesting an additional protective mechanism beyond its direct antiviral effects.
This research opens up exciting new avenues for extending our “healthspan” – the period of our lives spent in good health. By harnessing the power of these p16-high immune cells, we may be able to bolster our resilience against both acute diseases and the chronic wear and tear associated with aging, ultimately helping us live healthier, longer lives.
Source: link to paper